Package Leaflet: Information for the User
Grepid 75 mg film-coated tablets
clopidogrel
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Grepid contains clopidogrel and belongs to a group of medicines called antiplatelet agents. Platelets are very small cells in the blood that help the blood to clot. Antiplatelet agents prevent platelet clumping, reducing the risk of blood clots (a process called thrombosis).
Grepid is given to adults to prevent blood clots (thrombi) in blood vessels (arteries) that have become hardened (a process known as atherothrombosis), which can lead to atherothrombotic events (such as stroke, myocardial infarction, or death).
You have been prescribed Grepid to help prevent blood clots and reduce the risk of these serious events because:
Do not take Grepid
If you think any of these apply to you, or if you are unsure, consult your doctor before taking Grepid.
Warnings and precautions
Before starting treatment with Grepid, inform your doctor if you are in any of the following situations:
During treatment with Grepid:
Children and adolescents
This medicine should not be given to children as it is not effective.
Taking Grepid with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
Some medicines may affect the use of Grepid or vice versa.
You must specifically inform your doctor if you are taking:
If you have had severe chest pain (unstable angina or myocardial infarction), a transient ischemic attack, or a mild ischemic stroke, you may have been prescribed Grepid in combination with acetylsalicylic acid, a substance found in many medications used to relieve pain and reduce fever. A dose of acetylsalicylic acid given occasionally (not exceeding 1,000 mg in 24 hours) is generally not a problem, but prolonged use in other circumstances should be discussed with your doctor.
Taking Grepid with food and drinks
Grepid can be taken with or without food.
Pregnancy and breastfeeding
It is preferable not to take this medicine during pregnancy.
If you are pregnant or think you may be pregnant, you must inform your doctor or pharmacist before taking Grepid. If you become pregnant while taking Grepid, consult your doctor immediately, as it is not recommended to take Grepid during pregnancy.
You should not breastfeed while taking this medicine.
If you are breastfeeding or plan to breastfeed, inform your doctor before taking this medicine.
Consult your doctor or pharmacist before using any medicine.
Driving and using machines
Grepid is unlikely to affect your ability to drive or use machines.
Grepid contains lactose
If your doctor has told you that you have an intolerance to some sugars (e.g. lactose), consult him before taking this medicine.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The recommended dose, even for patients with a condition called "atrial fibrillation" (an irregular heartbeat), is one 75 mg Grepid tablet per day, taken orally with or without food and at the same time each day.
If you have had severe chest pain (unstable angina or myocardial infarction), your doctor may prescribe you 300 mg or 600 mg of Grepid (4 or 8 tablets of 75 mg) to be taken once at the start of treatment. After that, the recommended dose is one 75 mg Grepid tablet per day as described above.
If you have experienced symptoms of a stroke that disappear within a short period (also known as a transient ischemic attack) or a mild ischemic stroke, your doctor may prescribe you 300 mg of Grepid (4 tablets of 75 mg) once at the start of treatment. After that, the recommended dose is one 75 mg Grepid tablet per day as described above, with acetylsalicylic acid for 3 weeks. After that, your doctor will prescribe either Grepid alone or acetylsalicylic acid alone.
You should take Grepid for as long as your doctor continues to prescribe it.
If you take more Grepid than you should
Contact your doctor or go to the nearest hospital emergency department, as there is a higher risk of bleeding.
If you forget to take Grepid
If you forget to take a dose of Grepid, but remember before 12 hours have passed since the time you should have taken the medication, take the tablet immediately and the next one at the usual time.
If you forget for more than 12 hours, simply take the next dose at the usual time. Do not take a double dose to make up for a forgotten tablet.
If you stop taking Grepid
Do not stop your treatment unless your doctor tells you to. Contact your doctor or pharmacist before stopping this medicine.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Grepid can cause side effects, although not everybody gets them.
Contact your doctor immediately if you experience:
The most common side effect reported with Grepid is bleeding.Bleeding may occur in the stomach or intestine, bruising, hematoma (abnormal bleeding or bruising under the skin), nosebleeds, blood in urine. A small number of cases of bleeding from the blood vessels of the eyes, intracranial bleeding, pulmonary bleeding, or joint bleeding have also been reported.
If you experience prolonged bleeding while taking Grepid
If you cut or injure yourself, the bleeding may take a little longer than usual to stop. This is related to the mechanism of action of the medicine, as it prevents the blood from forming clots. For minor cuts or injuries, such as cuts while shaving, this is not a problem. However, if you are concerned about your bleeding, consult your doctor immediately (see section 2 "Warnings and precautions").
Other side effects include:
Common side effects (may affect up to 1 in 10 people):
Diarrhea, abdominal pain, indigestion, or heartburn.
Uncommon side effects (may affect up to 1 in 100 people):
Headache, stomach ulcer, vomiting, nausea, constipation, excess gas in the stomach or intestine, rash, itching, dizziness, tingling, and numbness.
Rare side effects (may affect up to 1 in 1,000 people):
Dizziness, breast enlargement in men.
Very rare side effects (may affect up to 1 in 10,000 people):
Jaundice; severe abdominal pain with or without back pain; fever, difficulty breathing, sometimes associated with cough; generalized allergic reactions (e.g. general feeling of heat with sudden general discomfort leading to fainting); swelling of the mouth; blisters on the skin, skin allergy; inflammation of the mouth mucosa (stomatitis); decreased blood pressure; confusion; hallucinations; joint pain; muscle pain; changes in taste or loss of taste of food.
Side effects with unknown frequency (cannot be estimated from the available data): Hypersensitivity reactions with chest or abdominal pain, persistent symptoms of low blood sugar.
In addition, your doctor may observe changes in the results of your blood or urine tests.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister, after EXP. The expiry date is the last day of the month stated.
See the storage conditions in the carton.
Store below 25°C when Grepid is presented in PVC/PE/PVDC/aluminum blisters.
When Grepid is presented in any aluminum blister, it does not require special storage conditions.
Do not use this medicine if you notice any visible signs of deterioration.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Grepid Composition
Tablet core:microcrystalline cellulose, hydroxypropylcellulose (E463), mannitol (E421), crospovidone (type A), citric acid monohydrate, macrogol 6000, stearic acid, and talc
Tablet coating:hypromellose (E464), red iron oxide (E172), lactose monohydrate, triacetin (E1518), and titanium dioxide (E171).
Product Appearance and Package Contents
Grepid film-coated tablets are pink, round, and biconvex.
They are available in cardboard boxes containing 10, 14, 28, 30, 50, 84, 90, or 100 film-coated tablets in PVC/PE/PVDC/Aluminum or PA/ALU/PVC/Aluminum blisters.
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Pharmathen S.A.,
6 Dervenakion
15351 Pallini Attiki
Greece
Manufacturers
Pharmathen S.A.,
6 Dervenakion
15351 Pallini Attiki
Greece
or
Pharmathen International S.A.
Industrial Park Sapes,
Rodopi Prefecture, Block No 5,
Rodopi 69300,
Greece
or
Orifarm Generics A/S
Energivej 15
5260 Odense S,
Denmark
For further information about this medicinal product, please contact the local representative of the marketing authorization holder.
Belgium Pharmathen S.A. Tel: +30 210 66 04 300 | Lithuania SIA ELVIM Tel: +371 67808450 |
Greece Pharmathen S.A. Tel: +30 210 66 04 300 | Luxembourg Pharmathen S.A. Tel: +30 210 66 04 300 |
Czech Republic Pharmathen S.A. Tel: +30 210 66 04 300 | Hungary Pharmathen S.A. Tel: +30 210 66 04 300 |
Denmark Orifarm Generics A/S Tel: +45 63 95 27 00 | Malta Pharmathen S.A. Tel: +30 210 66 04 300 |
Germany Glenmark Arzneimittel GmbH Tel: +49 8142 44392 0 | Netherlands Glenmark Pharmaceuticals B.V. Tel: +31 (0)8003355533 |
Estonia Pharmathen S.A. Tel: +30 210 66 04 300 | Norway Orifarm Generics AS Tel: +47 21 69 69 10 |
Greece INNOVIS PHARMA ΑΕΒΕ Tel: +30 210 6664805-806 | Austria Pharmathen S.A. Tel: +30 210 66 04 300 |
Spain Pharmathen S.A. Tel: +30 210 66 04 300 | Poland Symphar Sp. z o.o. Tel: +48 22 822 93 06 |
France Pharmathen S.A. Tel: +30 210 66 04 300 | Portugal Pharmathen S.A. Tel: +30 210 66 04 300 |
Croatia Pharmathen S.A. Tel: +30 210 66 04 300 | Romania Neola Pharma SRL Tel: +40-(0)21-233 17 81 |
Ireland Pinewood Healthcare Tel: +353 52 6186000 | Slovenia Pharmathen S.A. Tel: +30 210 66 04 300 |
Iceland Alvogen ehf. Tel: +354 522 2900 | Slovakia Valeant Slovakia s.r.o. Tel: +421 2 6920 3921 |
Italy Pharmathen S.A. Tel: +30 210 66 04300 | Finland Pharmathen S.A. Tel: +30 210 66 04 300 |
Cyprus The Star Medicines Importers Co. Ltd Tel: +357 25371056 | Sweden Orifarm Generics AB Tel: +46 40 680 02 60 |
Latvia SIA ELVIM Tel: +371 67808450 | United Kingdom(Northern Ireland) Athlone Pharmaceuticals Tel: +44 (0) 845 4375565 |
Date of last revision of this leaflet: July 2022
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu/